Search research articles
Contact Us
Filters
Showing results (21-30 of 51) with videos related to
Page
of 6
Sort By:
NDT Plus
|
May 19, 2015
Effects of reducing the lactate and glucose content of PD solutions on the peritoneum. Is the future GLAD?
Raymond T Krediet, Machteld M Zweers, Roos van Westrhenen, et al.
The Journal of Laboratory and Clinical Medicine
|
August 12, 1999
Growth factors VEGF and TGF-beta1 in peritoneal dialysis
M M Zweers, D R de Waart, W Smit, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis
|
December 6, 2007
What can we do to preserve the peritoneum?
Raymond T Krediet, Machteld M Zweers, Roos van Westrhenen, et al.
Journal of Veterinary Pharmacology and Therapeutics
|
June 1, 1996
Cytochrome P4502E in vivo and in vitro in the dwarf goat: effects of enzyme induction and the applicability of chlorzoxazone as marker substrate
W M Zweers-Zeilmaker, R F Maas, G J Horbach, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis
|
February 7, 2004
The effect of dwell time on dialysate cancer antigen 125 appearance rates in patients on continuous ambulatory peritoneal dialysis
Sema Akman, Roos van Westrhenen, Dirk R De Waart, et al.
The Journal of Urology
|
February 1, 1997
Oral desmopressin as a new treatment modality for primary nocturnal enuresis in adolescents and adults: a double-blind, randomized, multicenter study. Dutch Enuresis Study Group
R A Janknegt, H M Zweers, K P Delaere, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis
|
January 1, 1996
Demonstration of aquaporin-CHIP in peritoneal tissue of uremic and CAPD patients
M M Pannekeet, J B Mulder, J J Weening, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis
|
October 25, 2000
Dialysate cancer antigen 125 levels in children treated with peritoneal dialysis
A H Bouts, J W Groothoff, S P van Amstel, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
November 1, 1996
In vitro and in vivo oxidative biotransformation in the West-African dwarf goat (Caprus hircus aegagrus): substrate activities and effects of inducers
W M Zweers-Zeilmaker, J Batzias, R F Maas, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis
|
September 1, 2004
Does lymphatic absorption change with the duration of peritoneal dialysis?
Wieneke M Michels, Machteld M Zweers, Watske Smit, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 51) with videos related to
Sort By:
Page
of 6
NDT Plus
|
May 19, 2015
Effects of reducing the lactate and glucose content of PD solutions on the peritoneum. Is the future GLAD?
Raymond T Krediet, Machteld M Zweers, Roos van Westrhenen, et al.
The Journal of Laboratory and Clinical Medicine
|
August 12, 1999
Growth factors VEGF and TGF-beta1 in peritoneal dialysis
M M Zweers, D R de Waart, W Smit, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis
|
December 6, 2007
What can we do to preserve the peritoneum?
Raymond T Krediet, Machteld M Zweers, Roos van Westrhenen, et al.
Journal of Veterinary Pharmacology and Therapeutics
|
June 1, 1996
Cytochrome P4502E in vivo and in vitro in the dwarf goat: effects of enzyme induction and the applicability of chlorzoxazone as marker substrate
W M Zweers-Zeilmaker, R F Maas, G J Horbach, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis
|
February 7, 2004
The effect of dwell time on dialysate cancer antigen 125 appearance rates in patients on continuous ambulatory peritoneal dialysis
Sema Akman, Roos van Westrhenen, Dirk R De Waart, et al.
The Journal of Urology
|
February 1, 1997
Oral desmopressin as a new treatment modality for primary nocturnal enuresis in adolescents and adults: a double-blind, randomized, multicenter study. Dutch Enuresis Study Group
R A Janknegt, H M Zweers, K P Delaere, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis
|
January 1, 1996
Demonstration of aquaporin-CHIP in peritoneal tissue of uremic and CAPD patients
M M Pannekeet, J B Mulder, J J Weening, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis
|
October 25, 2000
Dialysate cancer antigen 125 levels in children treated with peritoneal dialysis
A H Bouts, J W Groothoff, S P van Amstel, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
November 1, 1996
In vitro and in vivo oxidative biotransformation in the West-African dwarf goat (Caprus hircus aegagrus): substrate activities and effects of inducers
W M Zweers-Zeilmaker, J Batzias, R F Maas, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis
|
September 1, 2004
Does lymphatic absorption change with the duration of peritoneal dialysis?
Wieneke M Michels, Machteld M Zweers, Watske Smit, et al.
Page
of 6